Sosei Heptares Turns To AI In GPCR-Focused Drug Discovery Pact

Duo Is Using AI To Identify GPCR Targets Across Multiple Disease Areas

It is the first time that Sosei has used AI to identify new drug targets. • Source: Alamy

More from Business

More from Scrip